「TYROSINE」の共起表現一覧(1語右で並び替え)
該当件数 : 233件
| eucine, isoleucine) and aromatic (tryptophan, | tyrosine) amino acids. |
| eucine, isoleucine) and aromatic (tryptophan, | tyrosine) amino acids. |
| th activated aromatic rings, such as those of | tyrosine aminoacid. |
| Tyrosine aminotransferase is the first in a series of | |
| m of the transcription initiation site of the | tyrosine aminotransferase gene, for example. |
| d gluconeogenesis - glucose-6-phosphatase and | tyrosine aminotransferase |
| nemia is caused by a deficiency of the enzyme | tyrosine aminotransferase (EC 2.6.1.5), |
| diiodotyrosine aminotransferase, halogenated | tyrosine aminotransferase, and halogenated tyrosine tr |
| use include tyrase, phenylalanine deaminase, | tyrosine ammonia-lyase, L-tyrosine ammonia-lyase, phen |
| ( | tyrosine ammonia-lyases), and EC 4.3.1.26 |
| of norepinephrine depends on the presence of | tyrosine, an amino acid found in proteins such as meat |
| samples by the presence of cysteine, cystine, | tyrosine, and tryptophan side chains. |
| transmitters; the synthesis and catabolism of | tyrosine; and the metabolism of microsome. |
| o-Methyltyrosine or dansylalanine instead of | tyrosine, and by inserting genetically coded reporter |
| valine, isoleucine, methionine, | tyrosine, and phenylalanine. |
| This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis. |
| This enzyme participates in | tyrosine and phenylalanine catabolism. |
| This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and two-component |
| This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and novobiocin bi |
| This enzyme participates in phenylalanine, | tyrosine and tryptophan biosynthesis and aminoacyl-trn |
| Three isomers of | tyrosine are known. |
| n 1994, vWF was shown to be cleaved between a | tyrosine at position 1605 and a methionine at 1606 by |
| o be provided by the carboxylic acid group of | tyrosine because tracking of radioactivity indicated t |
| the turnip yellow mosaic virus genome whilst | tyrosine binds to the tRNA-like structure of the barle |
| The amino acid | tyrosine contains a single phenolic ring that may be o |
| In enzymology, a | tyrosine decarboxylase (EC 4.1.1.25) |
| umarylacetoacetate inhibits previous steps in | tyrosine degradation leading to an accumulation of tyr |
| e from the precursors mentioned above, namely | tyrosine, dopamine and their derivatives. |
| rts on the solvent exposure of tryptophan and | tyrosine), far-ultraviolet circular dichroism (180-250 |
| ingle amino acid, typically valine or another | tyrosine, form a short intra-molecular diphenylether c |
| studies, which show an initially low rate of | tyrosine formation for full-length PheOH. |
| However, the body can synthesise | tyrosine from phenylalanine, an essential amino acid. |
| e results from the experiments indicated that | tyrosine, glycine, methionine, and acetate are the pri |
| Tryptophan hydroxylase (TPH), | tyrosine hydroxylase (TH) and phenylalanine hydroxylas |
| Tyrosine hydroxylase (TH) inhibitors like metirosine ( | |
| shown to produce a uniform downregulation of | tyrosine hydroxylase protein and activity gene express |
| Tyrosine hydroxylase | |
| Alpha-methyl-p-tyrosine (AMPT) is a | tyrosine hydroxylase enzyme inhibitor. |
| dopaminegenic, experiments measure the enzyme | tyrosine hydroxylase, since this enzyme is need to syn |
| Analogously to phenylalanine hydroxylase and | tyrosine hydroxylase, this enzyme uses (6R)-L-erythro- |
| ogy to the enzymes phenylalanine hydroxylase, | tyrosine hydroxylase, tryptophan hydroxylase and nitri |
| within their 3'UTRs (rabbit lipoxygenase, rat | tyrosine hydroxylase, and human alpha(I)-collagen). |
| As a competitive inhibitor of | tyrosine hydroxylase, it prevents the conversion of ty |
| names in common use include pheochromocytoma | tyrosine hydroxylase-associated kinase, STK4, and tyro |
| e and cardiac norepinephrine, and inactivates | tyrosine hydroxylase. |
| esis of dopamine via inhibition of the enzyme | tyrosine hydroxylase. |
| It is an inhibitor of the enzyme | tyrosine hydroxylase. |
| he IE-ESR method was first used to detect the | tyrosine iminoxyl radical. |
| has demonstrated that removal of a c-terminal | tyrosine increased the K+ current more than 10-fold. |
| Tyrosine is not directly toxic to the liver or kidneys | |
| Tyrosine is the precursor to dopamine, which in turn i | |
| In addition, in the adrenal medulla, | tyrosine is converted into the catecholamine hormones |
| In dopaminergic cells in the brain, | tyrosine is converted to levodopa by the enzyme tyrosi |
| m of the hydrochloride monohydrate salt, is a | tyrosine kinase inhibitor. |
| activated by G protein-coupled receptors and | tyrosine kinase receptors. |
| HER2, a | tyrosine kinase receptor, is overexpressed by many can |
| includes an SH2 domain, an SH3 domain, and a | tyrosine kinase domain. |
| JAK3 encodes Janus kinase 3, a | tyrosine kinase that belongs to the Janus family. |
| family has four members: JAK1, JAK2, JAK3 and | tyrosine kinase 2 (TYK2). |
| are transmembrane proteins that act to block | tyrosine kinase signaling. |
| ncodes a B-cell-specific scaffold protein and | tyrosine kinase substrate that promotes tyrosine phosp |
| One such receptor-associated | tyrosine kinase is Janus kinase (JAK), many of whose e |
| , a SH2 domain and in the C-terminal part the | tyrosine kinase domain. |
| Neratinib (HKI-272) is a | tyrosine kinase inhibitor under investigation for the |
| This gene encodes a member of the | tyrosine kinase and, more specifically, the Janus kina |
| Other example of | tyrosine kinase receptors include the insulin receptor |
| The similarity of the proteins includes the | tyrosine kinase domains and extends amino-terminal to |
| This protein belongs to a subfamily of | tyrosine kinase receptors with a homology region to th |
| Tyrosine kinase with immunoglobulin-like and EGF-like | |
| a consequence of agonist stimulation of both | tyrosine kinase and G protein-coupled receptors. |
| kine receptors is typically associated with a | tyrosine kinase belonging to the Janus kinase (JAK) fa |
| zartinib (AC220) is a small molecule receptor | tyrosine kinase inhibitor that is currently under deve |
| Tyrosine kinase receptors, including the IGF-1 recepto | |
| sequences reveal that ALK is a novel receptor | tyrosine kinase having a putative transmembrane domain |
| L, encodes an unregulated, cytoplasm-targeted | tyrosine kinase that allows the cells to proliferate w |
| ll receives the LIN-3 signal via the receptor | tyrosine kinase LET-23 (P5.p and P7.p also receive LIN |
| Tyrosine kinase growth factor receptors activate mitog | |
| C-src | tyrosine kinase has been shown to interact with YTHDC1 |
| EC 2.7.12.1) is a kinase that can act as both | tyrosine kinase and serine/threonine kinase. |
| tracellular transduction of receptor-mediated | tyrosine kinase activators. |
| The RET proto-oncogene encodes a receptor | tyrosine kinase for members of the glial cell line-der |
| l motility, and morphogenesis by activating a | tyrosine kinase signaling cascade after binding to the |
| nsmembrane-spanning region, and a cytoplasmic | tyrosine kinase domain. |
| It encodes a protein with a | tyrosine kinase domain at the N-terminal end and a pro |
| f and instead associate with the TYRO protein | tyrosine kinase binding protein to transduce activatin |
| and neratinib, afatinib is a next generation | tyrosine kinase inhibitor (TKI) that irreversibly inhi |
| This protein has been shown to bind | tyrosine kinase TYK2, and thus may mediate the signali |
| Tir is also a receptor | tyrosine kinase (RTK) that initiates its intimate adhe |
| astic lymphoma kinase (ALK) also known as ALK | tyrosine kinase receptor or CD246 (cluster of differen |
| potent and selective multi-targeted receptor | tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3 |
| in patients with mutations of CD135 (FMS-like | tyrosine kinase 3 receptor). |
| th Arp2/3 is cortactin, which appears to link | tyrosine kinase signalling to cytoskeletal reorganizat |
| For example, the oncogenic form of the src | tyrosine kinase is not active and fails to transform c |
| c membrane-spanning segment and a cytoplasmic | tyrosine kinase domain. |
| emonstrated to express FLT1 (VEGFR1) receptor | tyrosine kinase which was functionally required for ef |
| International RTK consortium - The Receptor | Tyrosine Kinase (RTK) Networks Consortium is an organi |
| ly stimulate cellular responses by binding to | tyrosine kinase receptors (the VEGFRs) on the cell sur |
| to treatment with imatinib (Gleevec), another | tyrosine kinase inhibitor currently used as a first-li |
| the TCR by recruiting an enzyme, known as the | tyrosine kinase lck, which is essential for activating |
| The | tyrosine kinase activity, in turn, initiates a signal |
| tory cofactor NHE-RF2 (NHERF-2) also known as | tyrosine kinase activator protein 1 (TKA-1) or SRY-int |
| C-src | tyrosine kinase |
| It is a | tyrosine kinase inhibitor, being developed by AstraZen |
| NGF binds to high-affinity | tyrosine kinase receptor TrkA. |
| It belongs to the large class of | tyrosine kinase receptors. |
| Crenolanib is a | tyrosine kinase inhibitor that acts by specifically in |
| of epidermal growth factor receptor's (EGFR) | tyrosine kinase domain. |
| ABL2 is a cytoplasmic | tyrosine kinase which is closely related to but distin |
| Tyrosine kinase activity mediates the GC-C signaling p | |
| (also known as AG013736) is a small molecule | tyrosine kinase inhibitor under development by Pfizer. |
| Lck (or lymphocyte-specific protein | tyrosine kinase) is a protein that is found inside spe |
| ert domain receptor (KDR, a type III receptor | tyrosine kinase) also known as vascular endothelial gr |
| reatest sequence similarity to LTK (leukocyte | tyrosine kinase). |
| C-src | tyrosine kinase, also known as CSK, is a human protein |
| 4 residue on human leukocyte-specific protein | tyrosine kinase, which acts as a negative regulatory s |
| latelet-derived growth factor receptor PDGFR) | tyrosine kinase, inhibiting both PDGFRA and PDGFRB at |
| The BCR-ABL transcript encodes a | tyrosine kinase, which activates mediators of the cell |
| kinases, G-protein coupled receptor kinases, | tyrosine kinase, and cytomegalovirus pUL97 protein. |
| -Met/Hepatocyte Growth Factor receptor (HGFR) | tyrosine kinase, which is involved in the oncogenesis |
| Receptor | tyrosine kinase, as in fibroblast growth factor recept |
| Lck is a | tyrosine kinase, which phosphorylates tyrosine residue |
| um levels of PGF and sFlt-1 (soluble fms-like | tyrosine kinase-1, also known as soluble VEGF receptor |
| volved in the negative regulation of receptor | tyrosine kinase-coupled signaling processes. |
| G13 is also essential for receptor | tyrosine kinase-induced migration of fibroblast and en |
| k" or signal to one another, such as Receptor | tyrosine kinase. |
| 1 (acidic fibroblast growth factor)-activated | tyrosine kinase. |
| K3, HDAC3, Serum response factor and Bruton's | tyrosine kinase. |
| been shown to interact with E2F1 and Bruton's | tyrosine kinase. |
| ass IA PI 3-kinases are activated by receptor | tyrosine kinases (RTKs). |
| Tyrosine kinases recruited to a receptor following hor | |
| riminate between even closely related protein | tyrosine kinases such as EGFR and its close relative H |
| kinases act on both serine and threonine, the | tyrosine kinases act on tyrosine, and a number (dual-s |
| ough G protein-coupled receptors and receptor | tyrosine kinases stimulate this hydrolysis. |
| t, forming the largest sub-family of receptor | tyrosine kinases (RTKs). |
| osphorylated after activation of cell surface | tyrosine kinases such as the epidermal growth factor r |
| Growth factors bind to receptor | tyrosine kinases resulting in the polymerization of ac |
| s gene is phosphorylated by ZAP70/SYK protein | tyrosine kinases following activation of the T-cell an |
| Numerous tyrphostins/TKIs aiming at various | tyrosine kinases have been generated by the originator |
| ortactin is activated via phosphorylation, by | tyrosine kinases or serine/threonine kinases, in respo |
| Da) is activated by receptor and non-receptor | tyrosine kinases due to the presence of two SH2 and a |
| ated signaling, including integrins, receptor | tyrosine kinases (RTKs), cytokine receptors (JAK/STATs |
| Receptor | tyrosine kinases (RTKs) play a key role in the communi |
| tinib selectively inhibits class III receptor | tyrosine kinases, including FMS-related tyrosine kinas |
| -rich domain of Frizzled and several receptor | tyrosine kinases, which have roles in development, inc |
| Together with | tyrosine kinases, PTPs regulate the phosphorylation st |
| These are receptor | tyrosine kinases, so named because they mediate cell s |
| Lyn is a member of the Src family of protein | tyrosine kinases, which is mainly expressed in hematop |
| G-protein subunits, receptor and non-receptor | tyrosine kinases, endothelial nitric oxide synthase (e |
| The tie receptors are | tyrosine kinases, so named because they mediate cell s |
| (TKI) is a pharmaceutical drug that inhibits | tyrosine kinases, enzymes responsible for the activati |
| pite less study and understanding compared to | tyrosine kinases. |
| diverse proteins, including several receptor | tyrosine kinases. |
| wth factor receptor (EGFR) family of receptor | tyrosine kinases. |
| lar endothelial growth factor (VEGF) receptor | tyrosine kinases. |
| family of four structurally related receptor | tyrosine kinases. |
| RTK class III is a class of receptor | tyrosine kinases. |
| eptor is part of the large family of receptor | tyrosine kinases. |
| ligands of the Tie family of protein receptor | tyrosine kinases. |
| gand that binds to the Eph-family of receptor | tyrosine kinases. |
| ors used in treating cancer are inhibitors of | tyrosine kinases. |
| This enzyme participates in | tyrosine metabolism and alkaloid biosynthesis. |
| This enzyme participates in | tyrosine metabolism and cyanoamino acid metabolism. |
| This enzyme participates in | tyrosine metabolism and phenylalanine metabolism. |
| This enzyme participates in | tyrosine metabolism and nitrogen metabolism. |
| enzyme participates in 5 metabolic pathways: | tyrosine metabolism, phenylalanine metabolism, nitroge |
| ysis / gluconeogenesis, histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, and met |
| d threonine metabolism, histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, tryptop |
| 6 metabolic pathways: methionine metabolism, | tyrosine metabolism, phenylalanine metabolism, phenyla |
| n 5 metabolic pathways: histidine metabolism, | tyrosine metabolism, phenylalanine metabolism, phenyla |
| This enzyme participates in | tyrosine metabolism. |
| Catecholamine hormones produced from | tyrosine metabolism. |
| This enzyme participates in | tyrosine metabolism.. |
| One | tyrosine molecule is metabolised to dopamine which con |
| (S)-norcoclaurine is derived from two | tyrosine molecules after decarboxylation. |
| Nitrotyrosine is a product of | tyrosine nitration mediated by reactive nitrogen speci |
| mate which can then be used in phenylalanine, | tyrosine or tryptophan biosynthesis. |
| "Xxx" is either an aromatic (phenylalanine, | tyrosine) or a branched aliphatic (valine, isoleucine) |
| e III because of the possible accumulation of | tyrosine or other intermediaries. |
| Mescaline can be synthesized from | tyrosine or a hydroxylated phenylalanine. |
| In enzymology, a | tyrosine phenol-lyase (EC 4.1.99.2) is an enzyme that |
| the biosynthesis of the aromatic amino acids | tyrosine, phenylalanine, and tryptophan. |
| e is a member of the dual specificity protein | tyrosine phosphatase family. |
| Links to all 107 members of the protein | tyrosine phosphatase family can be found in the templa |
| to Saccharomyces cerevisiae Cdc14, a protein | tyrosine phosphatase involved in the exit of cell mito |
| well as the pro-diabetic target human protein | tyrosine phosphatase 1B (h-PTP 1B), which explain at l |
| unctions as an acid phosphatase and a protein | tyrosine phosphatase by hydrolyzing protein tyrosine p |
| Receptor | tyrosine phosphatase is a type of Enzyme-linked recept |
| It has been shown that new protein | tyrosine phosphatase (PTP) activity for EPPase. |
| of the Saccharomyces cerevisiae YVH1 protein | tyrosine phosphatase. |
| phorylation by serine/threonine phosphatases, | tyrosine phosphatases, or dual-specificity phosphatase |
| Upon binding, IL-12R-β2 becomes | tyrosine phosphorylated and provides binding sites for |
| s of other proteins, and its SH2 domain binds | tyrosine phosphorylated sequences. |
| ucture of the Shc SH2 domain Complexed with a | Tyrosine phosphorylated Peptide from the T-cell Recept |
| The | tyrosine phosphorylation of Trask is tightly regulated |
| He is well-known for discovering that | tyrosine phosphorylation is a fundamental mechanism fo |
| The | tyrosine phosphorylation of CDCP1 in cultured cells oc |
| ns, including RhoA-mediated contractility and | tyrosine phosphorylation in response to adhesion. |
| and a cytoplasmic tail containing a potential | tyrosine phosphorylation site that may bind SH2. |
| It stimulates | tyrosine phosphorylation processes including the Jak2/ |
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|